Hisamitsu Pharmaceutical’s ¥457 billion plan to go private is being seen as a prime example of a flight from public markets among Japan’s drugmakers, with analysts expecting more to follow. https://www.japantimes.co.jp/business/2026/01/08/companies/buyout-wave-seen-among-japanese-drugmakers/?utm_medium=Social&utm_source=mastodon #business #companies #hisamitsu #salonpas #pharmaceuticals #acquisitions #stocks #tse #pharmaceuticals #health #medicine

Hisamitsu Pharmaceutical surged the most in more than 47 years after the Japanese maker of pain-relief patches announced it would go private in a management buyout valued at about $2.9 billion. https://www.japantimes.co.jp/business/2026/01/07/markets/hisamitsu-shares-jump-buyout/?utm_medium=Social&utm_source=mastodon #business #markets #hisamitsu #salonpas #pharmaceuticals #acquisitions

Hisamitsu Pharmaceutical’s management is considering a takeover bid to privatize the Japanese maker of pain-relief patches in a deal that could be worth around ¥450 billion ($2.9 billion). https://www.japantimes.co.jp/business/2026/01/06/companies/salonpas-hisamitsu-tob/?utm_medium=Social&utm_source=mastodon #business #companies #hisamitsupharmaceutical #salonpas #pharmaceuticals